Ladenburg Thalmann Financial Services’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$16K Sell
250
-189
-43% -$11.6K ﹤0.01% 4255
2019
Q3
$25K Hold
439
﹤0.01% 3901
2019
Q2
$25K Buy
439
+136
+45% +$6.29K ﹤0.01% 3921
2019
Q1
$12K Buy
303
+53
+21% +$2.08K ﹤0.01% 4288
2018
Q4
$10K Hold
250
﹤0.01% 4279
2018
Q3
$10K Hold
250
﹤0.01% 4293
2018
Q2
$7K Hold
250
﹤0.01% 4441
2018
Q1
$7K Buy
250
+99
+66% +$3.32K ﹤0.01% 4441
2017
Q4
$6K Buy
151
+28
+23% +$994 ﹤0.01% 4456
2017
Q3
$5K Buy
+123
New +$3.86K ﹤0.01% 4401
2013
Q4
Sell
-93
Closed -$2K 3810
2013
Q3
$2K Sell
93
-190
-67% -$3.26K ﹤0.01% 3461
2013
Q2
$5K Buy
+283
New +$4.52K ﹤0.01% 3050

Other funds holding NRC

Ladenburg Thalmann Financial Services's NRC Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its NRC Health Common Stock (NRC) stake by 43% in Q4 2019, selling an estimated $11.6K and leaving 250 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4255.

Ladenburg Thalmann Financial Services first reported a position in NRC in Q2 2013 and has held it in 12 quarters since. The position peaked at $25K in Q3 2019. 103 funds tracked by Wall St. Rank hold NRC as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 250 shares of NRC Health Common Stock worth $16K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 189 NRC Health Common Stock shares in Q4 2019, an estimated $11.6K.
  • NRC Health Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4255 holding.
  • Ladenburg Thalmann Financial Services first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 12 quarters since.
  • Ladenburg Thalmann Financial Services's NRC Health Common Stock position peaked at $25K in Q3 2019.
  • 103 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.